Dr. Paul Beaule, MD, FRCSC
Claim this profileThe Ottawa Hospital
Studies Femoroacetabular Impingement
Studies Developmental Dysplasia of the Hip
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Paul Beaule, MD, FRCSC is currently running
Surgical Treatment
for Femoroacetabular Impingement
An abnormally formed hip joint (cam deformity) is a major cause of osteoarthritis (OA). Individuals may not experience any symptoms until OA is severe due to extensive cartilage loss and changes in underlying bone. A series of studies showed that the cam deformity can lead to the development of OA if left untreated, thus strongly suggesting a causal relationship. Currently, the cam deformity that causes pain is surgically removed to relieve the pain and treat the associated cartilage damage. Recent studies have demonstrated that surgical treatment leads to bone and cartilage changes that were related to improved function and reduced pain.
Recruiting1 award Phase 27 criteria
Blood Thinners
for Pulmonary Embolism Prevention After Hip and Knee Replacement
PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.
Recruiting5 awards Phase 47 criteria
More about Paul Beaule, MD, FRCSC
Clinical Trial Related7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Paul Beaule, MD, FRCSC has experience with
- MRI
- Warfarin
- Enteric Coated Aspirin
- Rivaroxaban
- Femoroacetabular Impingement Surgery
- Surgical Treatment
Breakdown of trials Paul Beaule, MD, FRCSC has run
Femoroacetabular Impingement
Developmental Dysplasia of the Hip
Congenital Hip Dislocation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Beaule, MD, FRCSC specialize in?
Paul Beaule, MD, FRCSC focuses on Femoroacetabular Impingement and Developmental Dysplasia of the Hip. In particular, much of their work with Femoroacetabular Impingement has involved treating patients, or patients who are undergoing treatment.
Is Paul Beaule, MD, FRCSC currently recruiting for clinical trials?
Yes, Paul Beaule, MD, FRCSC is currently recruiting for 2 clinical trials in Ottawa Ontario. If you're interested in participating, you should apply.
Are there any treatments that Paul Beaule, MD, FRCSC has studied deeply?
Yes, Paul Beaule, MD, FRCSC has studied treatments such as MRI, Warfarin, Enteric Coated Aspirin.
What is the best way to schedule an appointment with Paul Beaule, MD, FRCSC?
Apply for one of the trials that Paul Beaule, MD, FRCSC is conducting.
What is the office address of Paul Beaule, MD, FRCSC?
The office of Paul Beaule, MD, FRCSC is located at: The Ottawa Hospital, Ottawa, Ontario K1H 8L6 Canada. This is the address for their practice at the The Ottawa Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.